Navigation Links
Boston Scientific to Participate in Piper Jaffray PCR Post-Op Summit
Date:5/15/2009

NATICK, Mass., May 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray PCR Post-Op Summit in London.

Jim Tobin, President and Chief Executive Officer, will participate in a 40-minute question and answer session on Friday, May 22, beginning at approximately 9:30 a.m. London time.

A live webcast of Mr. Tobin's remarks will be available to all interested parties at Boston Scientific's website at www.bostonscientific.com Please visit for details on how to access the webcast. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Piper Jaffray. The replay will be archived and available in the Investor Relations site at www.bostonscientific.com on May 22 at approximately one hour after the conclusion of the session.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com

    CONTACT:  Paul Donovan
              508-650-8541 (office)
              508-667-5165 (mobile)
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696 (office)
              Investor Relations
              Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Raytheon Donates $100,000 to Fisher House Boston
2. Boston Scientific Announces Schedule for EuroPCR 2009
3. First Boston Pharma, LLC Acquires NutraMax Products, Inc.
4. Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
5. Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
6. Children's Hospital Boston Advances Cutting-Edge Technologies with its New Technology Development Fund
7. Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange
8. Boston Scientific to Participate in Bank of America and Merrill Lynch Conference
9. Wounded Warrior Project (WWP) Announces Support for Soldier Ride from Boston Scientific
10. Boston Scientific Announces Results For First Quarter Ended March 31, 2009
11. Equinox Fitness Clubs Continues National Expansion with the Opening of its Second Boston Location
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , ... April 29, 2016 , ... ... loans more flexibility in repaying their loans, more information about their loan terms ... when total outstanding student loan debt, including federal and private loans, has reached ...
(Date:4/29/2016)... Petersburg, Fla. (PRWEB) , ... April 29, 2016 ... ... Children’s Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have ... babies is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails ...
(Date:4/29/2016)... ... April 29, 2016 , ... Mobility Designed is redefining mobility with ... armpits, the M+D Crutch evenly distributes body weight from the elbow to the forearm. ... using the crutches than with other crutches. , Co-founders Max and Liliana Younger were ...
(Date:4/29/2016)... ... , ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent of ... deaths. More than 10,000 people are expected to die of melanoma this year. The risk ... one of the most commonly diagnosed cancers in young women. A recent breakthrough in genetic ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... Review, H1 2016" is a report that provides ... helps strengthen R&D pipelines by identifying new targets ... Company Profiles discussed in this H1 ... Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., ...
(Date:4/27/2016)... Italy , April 27, 2016 ... linear accelerator (MR-linac) platform will be the focal point ... meeting of the European Society for Radiotherapy & Oncology, ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and a ... physician to clearly see the patient,s anatomy in real ...
(Date:4/27/2016)... April 27, 2016 Shire plc (LSE: ... Poulton , Chief Financial Officer, will present at the Deutsche ... MA on Wednesday, May 04, 2016, 10:00 am ... be available on the Presentations and Webcasts section of Shire,s ... the webcast will be available on this same website for ...
Breaking Medicine Technology: